User profiles for "author:Simon Mastbergen"

Simon Mastbergen

University Medical Center Utrecht
Verified email at umcutrecht.nl
Cited by 5084

Functional articular cartilage repair: here, near, or is the best approach not yet clear?

SC Mastbergen, DBF Saris, FPJG Lafeber - Nature reviews …, 2013 - nature.com
In this Review we describe three approaches for cartilage tissue repair at the rheumatology–
orthopaedics interface: disease-modifying osteoarthritis (OA) drug (DMOAD) treatment; cell …

Pathophysiology of hemophilic arthropathy and potential targets for therapy

AE Pulles, SC Mastbergen, REG Schutgens… - Pharmacological …, 2017 - Elsevier
Hemophilia is a congenital clotting factor deficiency characterized by spontaneous and
trauma-related bleeding. Spontaneous bleeding shows a predilection for joints, and …

[HTML][HTML] Celecoxib: considerations regarding its potential disease-modifying properties in osteoarthritis

MC Zweers, TN de Boer, J van Roon… - Arthritis research & …, 2011 - Springer
Osteoarthritis (OA) is a degenerative joint disease characterized by progressive loss of
articular cartilage, subchondral bone sclerosis, osteophyte formation, and synovial …

Tissue structure modification in knee osteoarthritis by use of joint distraction: an open 1-year pilot study

F Intema, PM Van Roermund… - Annals of the …, 2011 - ard.bmj.com
Background Modification of joint tissue damage is challenging in late-stage osteoarthritis
(OA). Few options are available for treating end-stage knee OA other than joint replacement …

[HTML][HTML] A role for subchondral bone changes in the process of osteoarthritis; a micro-CT study of two canine models

YH Sniekers, F Intema, FPJG Lafeber… - BMC musculoskeletal …, 2008 - Springer
Background This study evaluates changes in peri-articular bone in two canine models for
osteoarthritis: the groove model and the anterior cruciate ligament transection (ACLT) …

[HTML][HTML] Differential direct effects of cyclo-oxygenase-1/2 inhibition on proteoglycan turnover of human osteoarthritic cartilage: an in vitrostudy

SC Mastbergen, NWD Jansen, JWJ Bijlsma… - Arthritis research & …, 2005 - Springer
Abstract Treatment of osteoarthritis (OA) with nonsteroidal anti-inflammatory drugs (NSAIDs)
diminishes inflammation along with mediators of cartilage destruction. However, NSAIDs …

Dorsal root ganglia macrophages maintain osteoarthritis pain

R Raoof, CM Gil, FPJG Lafeber… - Journal of …, 2021 - Soc Neuroscience
Pain is the major debilitating symptom of osteoarthritis (OA), which is difficult to treat. In OA
patients joint tissue damage only poorly associates with pain, indicating other mechanisms …

Joint distraction for osteoarthritis: clinical evidence and molecular mechanisms

MP Jansen, SC Mastbergen - Nature Reviews Rheumatology, 2022 - nature.com
Joint distraction, the prolonged mechanical separation of the bones at a joint, has emerged
as a joint-preserving treatment for end-stage osteoarthritis, with the gradually growing …

Five-year follow-up of knee joint distraction: clinical benefit and cartilaginous tissue repair in an open uncontrolled prospective study

JTAD van der Woude, K Wiegant… - Cartilage, 2017 - journals.sagepub.com
Objective In end-stage knee osteoarthritis, total knee arthroplasty (TKA) may finally become
inevitable. At a relatively young age, this comes with the risk of future revision surgery …

Synovial fluid hyaluronan mediates MSC attachment to cartilage, a potential novel mechanism contributing to cartilage repair in osteoarthritis using knee joint …

TG Baboolal, SC Mastbergen, E Jones… - Annals of the …, 2016 - ard.bmj.com
Objectives Knee joint distraction (KJD) is a novel, but poorly understood, treatment for
osteoarthritis (OA) associated with remarkable 'spontaneous' cartilage repair in which …